Robert Petit
Chief Scientific Officer, Advaxis.
Companies
- OS Therapies IncOfficer Aug 1, 2024 to now1
- AdvaxisChief Scientific Officer May 6, 2013 to Nov 7, 20182
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- OS Therapies Inc OSTX200,000 shares3$282.0K at $1.41Feb 13, 2026
As of each latest filing. The line shows shares held over time.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGAROS Therapies Inc, Officer
- 2SEC EDGARAdvaxis, Chief Scientific Officer
- 3